SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-088380
Filing Date
2021-07-01
Accepted
2021-07-01 18:32:48
Documents
1
Period of Report
2021-02-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121189-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2121189-5_4seq1.xml 4 9906
  Complete submission text file 0001104659-21-088380.txt   11309
Mailing Address C/O SURFACE ONCOLOGY 50 HAMPSHIRE ST., 8TH FLOOR CAMBRIDGE MA 02139
Business Address
GRAYZEL DAVID S. (Reporting) CIK: 0001732786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40544 | Film No.: 211067410

Mailing Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116
Business Address 200 BERKELEY STREET FLOOR 18 BOSTON MA 02116 617-443-2400
Aerovate Therapeutics, Inc. (Issuer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations